PHARMACOGENETIC STUDIES IN CARDIOLOGY: THE PROBLEM OF "DEPTH" OF THE ISSUE STUDY AND THE CORRECTNESS OF USING "GENETIC" TERMS

PHARMACOGENETIC STUDIES IN CARDIOLOGY: THE PROBLEM OF "DEPTH" OF THE ISSUE STUDY AND THE CORRECTNESS OF USING "GENETIC" TERMS

.

Bibliographic Details
Main Authors:	D. A. Sychev, G. I. Lifshits
Format:	Article
Language:	English
Published:	Столичная издательская компания 2018-03-01
Series:	Рациональная фармакотерапия в кардиологии
Online Access:	https://www.rpcardio.online/jour/article/view/1609

Similar Items

THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE
by: K. B. Mirzaev, et al.
Published: (2015-09-01)

THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE
by: K. B. Mirzaev, et al.
Published: (2015-09-01)

PHARMACOGENETIC TESTING OPPORTUNITIES IN CARDIOLOGY BASED ON EXOME SEQUENCING
by: N. V. Shcherbakova, et al.
Published: (2015-09-01)

PHARMACOGENETIC TESTING OPPORTUNITIES IN CARDIOLOGY BASED ON EXOME SEQUENCING
by: N. V. Shcherbakova, et al.
Published: (2015-09-01)

The value of pharmacogenetic markers for personalized approach to the statins treatment
by: N. V. Kokh, et al.
Published: (2013-09-01)

Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
by: Xandra García-González, et al.
Published: (2021-11-01)

Organo-protective effects of quinapril: pharmacogenetic aspects
by: D. A. Sychev, et al.
Published: (2011-04-01)

PHARMACOGENETIC ASPECTS OF NEW ORAL ANTICOAGULANTS APPLICATION
by: A. V. Kryukov, et al.
Published: (2017-07-01)

Taxanes induced peripheral neuropathy: mechanism of development and pharmacogenetic factors
by: L V Shestakova, et al.
Published: (2018-03-01)

Pharmacogenetics of alcohol addiction: current perspectives
by: Zastrozhin MS, et al.
Published: (2019-07-01)

Significance of pharmacogenetic testing in solution of problem of nonsteroid antirheumatic drugs administration gastro-intestinal safety
by: A Y Obzerina, et al.
Published: (2009-06-01)

“Female issue” in cardiology
by: V. B. Mychka, et al.
Published: (2010-08-01)

Impact of pharmacogenetic testing on the risk of bleedings and excessive hypocoagulation episodes in the use of warfarin: The first meta-analysis of Russian prospective studies
by: D A Sychev, et al.
Published: (2014-04-01)

Glycoprotein P pharmacogenetic assessment role in digoxin pharmacotherapy individualization: a new approach for an old problem
by: D. A. Sychev, et al.
Published: (2006-08-01)

Pharmacogenetics in rheumatology: drug therapy individualization perspectives
by: D. A. Sychev, et al.
Published: (2005-10-01)

Pharmacogenetic studies in Alzheimer disease
by: T. Zúñiga Santamaría, et al.
Published: (2022-05-01)

Genetics in Cardiology
by: Çetin Erol
Published: (2023-03-01)

Clinical pharmacogenetics of angiotensin II receptor blockers: new perspectives of pharmacotherapy individualization
by: D. A. Sychev, et al.
Published: (2006-04-01)

Mechanisms of development of antipsychotic-induced metabolic disorders: pharmacogenetic aspect
by: R. F. Nasyrova, et al.
Published: (2018-01-01)

APPLICATIONS OF PHARMACOGENETIC TESTING FOR PERSONALIZATION OF THERAPY WITH ORAL ANTICOAGULANTS IN RUSSIA
by: D. A. Sychev, et al.
Published: (2015-09-01)

APPLICATIONS OF PHARMACOGENETIC TESTING FOR PERSONALIZATION OF THERAPY WITH ORAL ANTICOAGULANTS IN RUSSIA
by: D. A. Sychev, et al.
Published: (2015-09-01)

Use of pharmacogenetic testing to prevent adverse drug reactions during statin therapy
by: N A Rumyantsev, et al.
Published: (2017-01-01)

Association Studies in Clinical Pharmacogenetics
by: Pablo Zubiaur, et al.
Published: (2022-12-01)

Pharmacogenetic markers to predict safety of antipsychotics in adolescents experiencing acute psychotic episodes
by: D. Ivashchenko, et al.
Published: (2022-06-01)

PHARMACOGENETICS OF ANTITHROMBOTIC DRUGS: STATUS UPDATE ON THE PROBLEM
by: Ekaterina S. Kropacheva
Published: (2018-12-01)

Comparative clinical and economic evaluation of pharmacogenetic testing application for dabigatran in patients with atrial fibrillation
by: Sh P Abdullaev, et al.
Published: (2019-08-01)

Pharmacogenetics biomarkers of antipsychotics’ safety in adolescents with acute psychotic episode
by: D. V. Ivashchenko, et al.
Published: (2019-12-01)

Satisfaction survey with DNA cards method to collect genetic samples for pharmacogenetics studies
by: Mas Herrero Sergio, et al.
Published: (2006-05-01)

VARFARIN DOSE REGIME APPROACHS BASED ON PHARMACOGENETICS TEST RESULTS: REAL POSSIBILITY TO OPTIMIZE THE PHARMACOTHERAPY
by: D. A. Sychev, et al.
Published: (2015-12-01)

VARFARIN DOSE REGIME APPROACHS BASED ON PHARMACOGENETICS TEST RESULTS: REAL POSSIBILITY TO OPTIMIZE THE PHARMACOTHERAPY
by: D. A. Sychev, et al.
Published: (2015-12-01)

Pharmacogenetics of schizophrenia.
by: Reynolds, G, et al.
Published: (2006)

Therapeutic resistance in depression from the genetics and pharmacogenetics point of view
by: G. E. Mazo, et al.
Published: (2019-12-01)

NOTION OF INTERNATIONAL FINANCIAL LAW: SPECIFIC ISSUES
by: I. M. Lifshits
Published: (2018-04-01)

Pharmacogenetics of HMG-CoA reductase inhibitors (statins): perspectives of individualized, genotype-based therapy
by: D. A. Sychev, et al.
Published: (2006-02-01)

Pharmacogenetics of carbamazepine
by: N. A. Shnayder, et al.
Published: (2020-01-01)

Pharmacogenetics of Antidepressants: from Genetic Findings to Predictive Strategies
by: L. K. Khokhlov, et al.
Published: (2019-05-01)

Asthma pharmacogenetics and the development of genetic profiles for personalized medicine
by: Ortega VE, et al.
Published: (2015-01-01)

Analysis of the complications of endocrine therapy with tamoxifen in breast cancer: clinical and pharmacogenetic aspects. Prospective pharmacogenetic cohort study
by: Marina I. Savelyeva, et al.
Published: (2022-11-01)

APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY
by: D. A. Sychev, et al.
Published: (2015-09-01)

APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY
by: D. A. Sychev, et al.
Published: (2015-09-01)